Indications for adjuvant radiotherapy in breast cancer Armenian consensus 2021-2022
Author:
Affiliation:
1. “IRA Medical Group” Medical Center, Yerevan, Armenia. Department of Oncology, Avdalbekyan National Institute of Health, MoH, RA, Yerevan, Armenia
2. Department of Oncology, Avdalbekyan National Institute of Health, MoH, RA, Yerevan, Armenia
Abstract
Publisher
National Institute of Health
Reference18 articles.
1. Bray F, Ferlay J, Soerjomataram I et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [published correction appears in CA Cancer J Clin 2020;70(4):313]. CA Cancer J Clin. 2018;68(6):394-424.
2. Barton MB, Jacob S, Shafiq J et al. Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother Oncol. 2014;112(1):140-144
3. Van Maaren MC, de Munck L, de Bock GH et al. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. Lancet Oncol. 2016;17:1158-1170
4. NCCN Clinical Practice Guidelines in Oncology; Breast Cancer. Version 2.2022-December 20, 2021
5. Halperin EC, Wazer DE, Perez CA, Brady LW. Perez and Brady’s Principles and Practice of Radiation Oncology. 7th edition. USA, Wolters Kluwer, 2019:3939-4417
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3